Atracurium is a competitive neuromuscular blocking agent. Laboratory and clinical studies indicate that it is rapidly metabolized and lacks cumulative effects. A 29-year-old woman exhibited prolonged neuromuscular weakness after receiving atracurium. This report questions the claims that atracurium has no cumulative effects, that there is 95 per cent recovery from blockade within 60 minutes after injection, and that reversal is readily attained within eight to ten minutes.
Case ReportA 29-year-old woman presented for exploratory
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.